Discovering new treatments for GI and liver diseases
The Division of Gastroenterology and Hepatology is committed to discovering novel therapies for gastroenterology and liver diseases.
Overview
The primary research goal of the Division of Gastroenterology and Hepatology is to create scientific discoveries relevant to gastrointestinal and liver diseases and translate those discoveries into clinical practice. The division supports and maintains fundamental, lab-based research programs and clinical research programs focused on pathophysiology, epidemiology, innovative diagnostic tools and the conduct of clinical trials. The division supports robust career development opportunities for its investigators to ensure future success of its mission of providing the best care to every patient, every day.
The division's research funding comes from the National Institutes of Health, industry partners, nonprofit foundations and Mayo Clinic. Generous gifts from our benefactors, patients and families also support the division. The division initiates hundreds of clinical trials and publishes hundreds of articles, editorials and reviews each year.
Research topics span the breadth of gastroenterology and hepatology and include:
- The study of novel treatments for liver and pancreatic diseases.
- Investigation of new technologies to identify and treat inflammatory bowel disease, irritable bowel syndrome and other motility disorders.
- Developing and evaluating cutting-edge endoscopic technology and procedures.